| First Author | Walesky C | Year | 2013 |
| Journal | Hepatology | Volume | 57 |
| Issue | 6 | Pages | 2480-90 |
| PubMed ID | 23315968 | Mgi Jnum | J:316623 |
| Mgi Id | MGI:6839761 | Doi | 10.1002/hep.26251 |
| Citation | Walesky C, et al. (2013) Hepatocyte nuclear factor 4 alpha deletion promotes diethylnitrosamine-induced hepatocellular carcinoma in rodents. Hepatology 57(6):2480-90 |
| abstractText | Hepatocyte nuclear factor 4 alpha (HNF4alpha), the master regulator of hepatocyte differentiation, has been recently shown to inhibit hepatocyte proliferation by way of unknown mechanisms. We investigated the mechanisms of HNF4alpha-induced inhibition of hepatocyte proliferation using a novel tamoxifen (TAM)-inducible, hepatocyte-specific HNF4alpha knockdown mouse model. Hepatocyte-specific deletion of HNF4alpha in adult mice resulted in increased hepatocyte proliferation, with a significant increase in liver-to-body-weight ratio. We determined global gene expression changes using Illumina HiSeq-based RNA sequencing, which revealed that a significant number of up-regulated genes following deletion of HNF4alpha were associated with cancer pathogenesis, cell cycle control, and cell proliferation. The pathway analysis further revealed that c-Myc-regulated gene expression network was highly activated following HNF4alpha deletion. To determine whether deletion of HNF4alpha affects cancer pathogenesis, HNF4alpha knockdown was induced in mice treated with the known hepatic carcinogen diethylnitrosamine (DEN). Deletion of HNF4alpha significantly increased the number and size of DEN-induced hepatic tumors. Pathological analysis revealed that tumors in HNF4alpha-deleted mice were well-differentiated hepatocellular carcinoma (HCC) and mixed HCC-cholangiocarcinoma. Analysis of tumors and surrounding normal liver tissue in DEN-treated HNF4alpha knockout mice showed significant induction in c-Myc expression. Taken together, deletion of HNF4alpha in adult hepatocytes results in increased hepatocyte proliferation and promotion of DEN-induced hepatic tumors secondary to aberrant c-Myc activation. |
